Maximizing Community Oncology Practice Value

How to Maximize Oncology Practice Value

Community oncology practices are forced to navigate dramatic market shifts. Mergers and acquisitions, fee schedule changes, increased competition with hospitals, and Covid-19 disruptions are a few recent developments making impacts. Boosting EBITDA in the near-term is critical to best position your organization for a sale, merger, partnership, and/or long-term viability.

Download this white paper to learn about:

  • Billing headaches that affect EBITDA the most in community oncology
  • The right analytics tools for managing financial performance
  • Automating prior authorization and other needed functionality
  • Improving payor denial management
  • And more